Depression and Anxiety Trial, Recruiting
Who may be able to join
AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI
Who might be able to join this trial:
For healthcare professionals and researchers (Aim 1):
- People who have been personally invited by a member of the study team
- People working in healthcare (such as doctors, nurses, or pharmacists), patient advocacy, healthcare or technology research, or healthcare administration and management
- People aged 18 or older
- People who speak English
- People who are willing and able to give their informed consent to participate
For older cancer survivors living in rural areas (Aim 2):
- People who live in a rural area, as defined by the Health Resources & Services Administration (HRSA) rural classification system
- People who report having been diagnosed with any type of cancer
- People who report having finished their main cancer treatment (such as surgery, chemotherapy, targeted therapy, or hormone therapy) aimed at curing the cancer
- People who have access to a computer, smartphone, or tablet
- People aged 65 or older
- People whose screening results show a Cancer and Treatment Distress (CTXD) score above 0.85 (the trial site will assess this)
- People who have a caregiver who is willing to take part in the study
- People who are not living in an institution (such as a nursing home or care facility)
- People who are sufficiently proficient in English to participate
- People who are willing and able to give their informed consent to participate
For caregivers (Aim 2):
- People who are an informal caregiver (such as a partner, child, or friend) of an eligible rural older cancer survivor participating in this trial — caregivers may live in a rural or urban area and do not need to live with the cancer survivor
- People who have access to the internet
- People aged 18 or older
- People who are not living in an institution
- People who are sufficiently proficient in English to participate
- People who are willing and able to give their informed consent to participate
For the final workshop (Aim 3):
- People working as healthcare providers, medical or practice managers, patient care coordinators, or medical health technologists
Who may not be able to join:
For older cancer survivors living in rural areas (Aim 2):
- People whose cancer comes back, or who receive a new cancer diagnosis, while they are participating in the trial
- People who are currently admitted as inpatients in a hospital or medical facility
- People whose cognitive (thinking or memory) difficulties would prevent them from being able to give written informed consent
For caregivers (Aim 2):
- People who are currently admitted as inpatients in a hospital or medical facility
- People whose cognitive (thinking or memory) difficulties would prevent them from being able to give written informed consent
Important: Always verify eligibility with the trial site directly before applying.
Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.
Contact this trial
Principal Investigator: Marquita W Lewis, PhD, Northwestern University
Phone: 312-503-1986
Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.
GP referral letter
Print a one-page summary to share with your doctor.
Trial details
Where this trial is recruiting
Primary endpoints
Cancer Related Distress (validated 23-item scale)
Can't join this trial?
Data last synced from ClinicalTrials.gov: 13 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.